NCT03921021 · Interventional trial
Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Overall registry status Completed
Phase 2
Conditions Esophagogastric Adenocarcinoma
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory